Literature DB >> 16193284

Latent autoimmune diabetes in adults (LADA) should be less latent.

S Fourlanos1, F Dotta, C J Greenbaum, J P Palmer, O Rolandsson, P G Colman, L C Harrison.   

Abstract

'Latent autoimmune diabetes in adults' (LADA) is the term coined to describe adults who have a slowly progressive form of autoimmune or type 1 diabetes that can be treated initially without insulin injections. The diagnosis of LADA is currently based on three clinical criteria: (1) adult age at onset of diabetes; (2) the presence of circulating islet autoantibodies, which distinguishes LADA from type 2 diabetes; and (3) insulin independence at diagnosis, which distinguishes LADA from classic type 1 diabetes. The prevalence of LADA in adults presenting with non-insulin-requiring diabetes is approximately 10%. Recognition of LADA expands the concept and prevalence of autoimmune diabetes, but LADA remains poorly understood at both a clinical and research level. In this perspective, we review the nomenclature, diagnostic criteria, genetics, pathology and therapy of LADA, to arrive at recommendations that might advance knowledge and management of this form of diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16193284     DOI: 10.1007/s00125-005-1960-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  58 in total

1.  Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA).

Authors:  A Carlsson; G Sundkvist; L Groop; T Tuomi
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

2.  Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study.

Authors:  T M Davis; P Zimmet; W A Davis; D G Bruce; S Fida; I R Mackay
Journal:  Diabet Med       Date:  2000-09       Impact factor: 4.359

3.  Thyroid function, morphology and autoimmunity in young patients with insulin-dependent diabetes mellitus.

Authors:  D Hansen; F N Bennedbaek; L K Hansen; M Hoier-Madsen; B B Jacobsen; L Hegedüs
Journal:  Eur J Endocrinol       Date:  1999-06       Impact factor: 6.664

4.  The Finnish Diabetes Prevention Study.

Authors:  M Uusitupa; A Louheranta; J Lindström; T Valle; J Sundvall; J Eriksson; J Tuomilehto
Journal:  Br J Nutr       Date:  2000-03       Impact factor: 3.718

5.  Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe.

Authors:  Bernard Zinman; Steven E Kahn; Steven M Haffner; M Colleen O'Neill; Mark A Heise; Martin I Freed
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

Review 6.  Autoimmune thyroid disease: propagation and progression.

Authors:  Anthony P Weetman
Journal:  Eur J Endocrinol       Date:  2003-01       Impact factor: 6.664

7.  Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes.

Authors:  Tetsuro Kobayashi; Shoichiro Tanaka; Minoru Okubo; Koji Nakanishi; Toshio Murase; Ake Lernmark
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

8.  Variable number of tandem repeats of the insulin gene determines susceptibility to latent autoimmune diabetes in adults.

Authors:  Gloria Edith Cerrone; Mariela Caputo; Ariel Pablo Lopez; Claudio González; Carmen Massa; Norberto Cédola; Héctor Manuel Targovnik; Gustavo Daniel Frechtel
Journal:  Mol Diagn       Date:  2004

9.  Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus.

Authors:  S Caillat-Zucman; H J Garchon; J Timsit; R Assan; C Boitard; I Djilali-Saiah; P Bougnères; J F Bach
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

10.  Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus.

Authors:  S Genovese; E Bonifacio; J M McNally; B M Dean; R Wagner; E Bosi; E A Gale; G F Bottazzo
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

View more
  89 in total

1.  Latent autoimmune diabetes in adults (LADA) is dead: long live autoimmune diabetes!

Authors:  O Rolandsson; J P Palmer
Journal:  Diabetologia       Date:  2010-03-25       Impact factor: 10.122

Review 2.  Epidemiology of type 1 diabetes.

Authors:  David M Maahs; Nancy A West; Jean M Lawrence; Elizabeth J Mayer-Davis
Journal:  Endocrinol Metab Clin North Am       Date:  2010-09       Impact factor: 4.741

3.  How to diagnose and classify diabetes in primary health care: lessons learned from the Diabetes Register in Northern Sweden (DiabNorth).

Authors:  Olov Rolandsson; Margareta Norberg; Lennarth Nyström; Stefan Söderberg; Maria Svensson; Bernt Lindahl; Lars Weinehall
Journal:  Scand J Prim Health Care       Date:  2012-06       Impact factor: 2.581

4.  Familial autoimmunity in neurological patients with GAD65 antibodies: an interview-based study.

Authors:  Sergio Muñiz-Castrillo; Alberto Vogrig; Clémentine Montagnac; Bastien Joubert; Marie Benaiteau; Olivier Casez; Hugo Chaumont; Lucie Hopes; Hélène-Marie Lanoiselée; Vincent Navarro; Benjamin Thomas; Renata Ursu; David Gonçalves; Nicole Fabien; François Ducray; Cécile Julier; Jérôme Honnorat
Journal:  J Neurol       Date:  2021-02-05       Impact factor: 4.849

Review 5.  Latent autoimmune diabetes in adults: a guide for the perplexed.

Authors:  E A M Gale
Journal:  Diabetologia       Date:  2005-11       Impact factor: 10.122

6.  Latent autoimmune diabetes in adults (LADA)--more than a name.

Authors:  L Groop; T Tuomi; M Rowley; P Zimmet; I R Mackay
Journal:  Diabetologia       Date:  2006-07-04       Impact factor: 10.122

7.  Comment on: Gale EAM (2005) Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia 48:2195-2199.

Authors:  A Clark; M Desai
Journal:  Diabetologia       Date:  2006-07-11       Impact factor: 10.122

Review 8.  Molecular mechanisms in autoimmune type 1 diabetes: a critical review.

Authors:  Zhiguo Xie; Christopher Chang; Zhiguang Zhou
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

9.  Worse glycaemic control in LADA patients than in those with type 2 diabetes, despite a longer time on insulin therapy.

Authors:  C D Andersen; L Bennet; L Nyström; U Lindblad; E Lindholm; L Groop; O Rolandsson
Journal:  Diabetologia       Date:  2012-10-25       Impact factor: 10.122

Review 10.  Diagnostic criteria of latent autoimmune diabetes in adults (LADA): a review and reflection.

Authors:  Yu Liao; Yufei Xiang; Zhiguang Zhou
Journal:  Front Med       Date:  2012-07-28       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.